rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Novacyt de volgende biotech raket!

70.915 Posts
Pagina: «« 1 ... 3518 3519 3520 3521 3522 ... 3546 »» | Laatste | Omlaag ↓
  1. forum rang 10 voda 3 mei 2024 17:56

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    0,787
    3-mei-2024 17:35:26
    Verschil
    -0,051 (-6,09%)
    Dagrange 0,786 - 0,839
    Volume
    304.028
    Gem. (3M) 185,9K
  2. forum rang 10 voda 3 mei 2024 17:59

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Slotkoers 31 dec. 2023 0,713

    Slotkoers 05 jan. 2024 0,6715 -0,0415 = -5.82%
    Slotkoers 12 jan. 2024 0,653 -0,0185 = -2.76%
    Slotkoers 19 jan. 2024 0,606 -0,047 = -7.20%
    Slotkoers 26 jan. 2024 0,555 -0,051 = -8.42%
    Slotkoers 02 feb. 2024 0,608 +0,053 = +9.55%
    Slotkoers 09 feb. 2024 0,576 -0,032 = -5.26%
    Slotkoers 16 feb. 2024 0,5615 -0,0145 = -2.52%
    Slotkoers 23 feb. 2024 0,564 +0,0025 = +0.45%
    Slotkoers 01 mrt. 2024 0,5245 -0,0395 = -7.00%
    Slotkoers 08 mrt. 2024 0,506 -0,0185 = -3.53%
    Slotkoers 15 mrt. 2024 0,545 +0,039 = +7.71%
    Slotkoers 22 mrt. 2024 0,521 -0,024 = -4.40%
    Slotkoers 28 mrt. 2024 0,517 -0,004 = -0.77%
    Slotkoers 05 apr. 2024 0,515 -0,002 = -0.39%
    Slotkoers 12 apr. 2024 0,593 +0,078 = +15.15%
    Slotkoers 19 apr. 2024 0,830 +0,237 = +39.97% Wauw, wat een super week zeg!!
    Slotkoers 26 apr. 2024 0,819 -0,011 = -1.33%
    Slotkoers 03 mei 2024 0,787 -0,032 = -3.91%

    Jaarrendement t.o.v. van 31 december 2023 +0,074 = +10.38%

    Maandrendementen: (t.o.v. slot vorige maand)

    Slotkoers 31 jan. 2024 0,6185 -0,0945 = -13.25%
    Slotkoers 29 feb. 2024 0,515 -0,1035 = -16.73%
    Slotkoers 28 mrt. 2024 0,517 +0,002 = +0.39%
    Slotkoers 30 apr. 2024 0,831 +0,314 = +60.74% !!!!!
    Slotkoers 03 mei 2024 0,787 -0,044 = -5.29%
  3. forum rang 10 voda 10 mei 2024 17:57

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Slotkoers 31 dec. 2023 0,713

    Slotkoers 05 jan. 2024 0,6715 -0,0415 = -5.82%
    Slotkoers 12 jan. 2024 0,653 -0,0185 = -2.76%
    Slotkoers 19 jan. 2024 0,606 -0,047 = -7.20%
    Slotkoers 26 jan. 2024 0,555 -0,051 = -8.42%
    Slotkoers 02 feb. 2024 0,608 +0,053 = +9.55%
    Slotkoers 09 feb. 2024 0,576 -0,032 = -5.26%
    Slotkoers 16 feb. 2024 0,5615 -0,0145 = -2.52%
    Slotkoers 23 feb. 2024 0,564 +0,0025 = +0.45%
    Slotkoers 01 mrt. 2024 0,5245 -0,0395 = -7.00%
    Slotkoers 08 mrt. 2024 0,506 -0,0185 = -3.53%
    Slotkoers 15 mrt. 2024 0,545 +0,039 = +7.71%
    Slotkoers 22 mrt. 2024 0,521 -0,024 = -4.40%
    Slotkoers 28 mrt. 2024 0,517 -0,004 = -0.77%
    Slotkoers 05 apr. 2024 0,515 -0,002 = -0.39%
    Slotkoers 12 apr. 2024 0,593 +0,078 = +15.15%
    Slotkoers 19 apr. 2024 0,830 +0,237 = +39.97% Wauw, wat een super week zeg!!
    Slotkoers 26 apr. 2024 0,819 -0,011 = -1.33%
    Slotkoers 03 mei 2024 0,787 -0,032 = -3.91%
    Slotkoers 10 mei 2024 0,788 +0,001 = +0.13%

    Jaarrendement t.o.v. van 31 december 2023 +0,075 = +10.52%

    Maandrendementen: (t.o.v. slot vorige maand)

    Slotkoers 31 jan. 2024 0,6185 -0,0945 = -13.25%
    Slotkoers 29 feb. 2024 0,515 -0,1035 = -16.73%
    Slotkoers 28 mrt. 2024 0,517 +0,002 = +0.39%
    Slotkoers 30 apr. 2024 0,831 +0,314 = +60.74% !!!!!
    Slotkoers 10 mei 2024 0,788 -0,043 = -5.17%
  5. forum rang 10 voda 17 mei 2024 17:53

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    0,721
    17-mei-2024 17:28:56
    Verschil
    -0,003 (-0,41%)
    Dagrange 0,721 - 0,737
    Volume
    37.510
    Gem. (3M) 194,5K
  6. forum rang 10 voda 17 mei 2024 17:56

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Slotkoers 31 dec. 2023 0,713

    Slotkoers 05 jan. 2024 0,6715 -0,0415 = -5.82%
    Slotkoers 12 jan. 2024 0,653 -0,0185 = -2.76%
    Slotkoers 19 jan. 2024 0,606 -0,047 = -7.20%
    Slotkoers 26 jan. 2024 0,555 -0,051 = -8.42%
    Slotkoers 02 feb. 2024 0,608 +0,053 = +9.55%
    Slotkoers 09 feb. 2024 0,576 -0,032 = -5.26%
    Slotkoers 16 feb. 2024 0,5615 -0,0145 = -2.52%
    Slotkoers 23 feb. 2024 0,564 +0,0025 = +0.45%
    Slotkoers 01 mrt. 2024 0,5245 -0,0395 = -7.00%
    Slotkoers 08 mrt. 2024 0,506 -0,0185 = -3.53%
    Slotkoers 15 mrt. 2024 0,545 +0,039 = +7.71%
    Slotkoers 22 mrt. 2024 0,521 -0,024 = -4.40%
    Slotkoers 28 mrt. 2024 0,517 -0,004 = -0.77%
    Slotkoers 05 apr. 2024 0,515 -0,002 = -0.39%
    Slotkoers 12 apr. 2024 0,593 +0,078 = +15.15%
    Slotkoers 19 apr. 2024 0,830 +0,237 = +39.97% Wauw, wat een super week zeg!!
    Slotkoers 26 apr. 2024 0,819 -0,011 = -1.33%
    Slotkoers 03 mei 2024 0,787 -0,032 = -3.91%
    Slotkoers 10 mei 2024 0,788 +0,001 = +0.13%
    Slotkoers 17 mei 2024 0,721 -0,067 = -8.50%

    Jaarrendement t.o.v. van 31 december 2023 +0,008 = +1.12%

    Maandrendementen: (t.o.v. slot vorige maand)

    Slotkoers 31 jan. 2024 0,6185 -0,0945 = -13.25%
    Slotkoers 29 feb. 2024 0,515 -0,1035 = -16.73%
    Slotkoers 28 mrt. 2024 0,517 +0,002 = +0.39%
    Slotkoers 30 apr. 2024 0,831 +0,314 = +60.74% !!!!!
    Slotkoers 17 mei 2024 0,721 -0,110 = -13.24%
  7. RAMO 22 mei 2024 16:14

    • RAMO

      Lid sinds: 18 mrt 2008

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 316

      Gegeven: 102

    •    Aantal posts: 328

    www.research-tree.com/newsfeed/articl...

    Novacyt S.A.

    ("Novacyt", the "Company" or the "Group")

    Notice of Results and Annual General Meeting

    Paris, France, and Eastleigh and Manchester, UK - 20 May 2024 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces that it will report its audited financial results for the year ended 31 December 2023 on Thursday, 30 May 2024.

    The Company also announces that its Annual General Meeting ("AGM") will be held at 2pm CEST/1pm BST on Wednesday, 26 June 2024 as an open virtual meeting. Further details of the AGM will be provided to shareholders in due course.

    Investor webinar

    An investor webinar presentation by Lyn Rees, Chief Executive Officer, and Steve Gibson, Chief Financial Officer, relating to the FY 2023 results will take place at 11.00am BST on Thursday, 30 May 2024.

    The webinar is open to all existing and potential investors, and will consist of a presentation followed by a Q&A session, held on the Investor Meet Company platform. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00am the day before the meeting or at any time during the live presentation. Automated French subtitling will be available throughout the presentation.
  8. forum rang 10 voda 23 mei 2024 15:04

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Zal volgens DZR wel weer een shuffle zijn. :-)

    € 0,791
    +0,061
    (+8,35%)
  12. forum rang 10 voda 23 mei 2024 18:25

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Toch een mooie dag zo.

    0,786
    23-mei-2024 17:38:16
    Verschil
    +0,056 (+7,67%)
    Dagrange 0,720 - 0,805
    Volume
    478.082
    Gem. (3M) 193,2K
  14. forum rang 10 voda 24 mei 2024 06:53

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    quote:

    DeZwarteRidder schreef op 23 mei 2024 16:49:

    De aandeelhouders van Novacit zitten te hopen op een uitbraak van de vogeltjesgriep.
    Daar hebben ze een paar jaar geleden wel een test voor ontwikkelt.

    Schijnt nu toch wel serieus te worden, zie ook deze draad in de koffiekamer.

    www.iex.nl/Forum/Topic/1373405/Koffie...
  15. forum rang 10 voda 24 mei 2024 17:58

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    0,777
    24-mei-2024 17:35:17
    Verschil
    -0,009 (-1,14%)
    Dagrange 0,756 - 0,800
    Volume
    220.248
    Gem. (3M) 200,1K
  16. forum rang 10 voda 24 mei 2024 17:59

    • voda

      Lid sinds: 02 dec 2005

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 93442

      Gegeven: 22909

    •    Aantal posts: 384.388

    Slotkoers 31 dec. 2023 0,713

    Slotkoers 05 jan. 2024 0,6715 -0,0415 = -5.82%
    Slotkoers 12 jan. 2024 0,653 -0,0185 = -2.76%
    Slotkoers 19 jan. 2024 0,606 -0,047 = -7.20%
    Slotkoers 26 jan. 2024 0,555 -0,051 = -8.42%
    Slotkoers 02 feb. 2024 0,608 +0,053 = +9.55%
    Slotkoers 09 feb. 2024 0,576 -0,032 = -5.26%
    Slotkoers 16 feb. 2024 0,5615 -0,0145 = -2.52%
    Slotkoers 23 feb. 2024 0,564 +0,0025 = +0.45%
    Slotkoers 01 mrt. 2024 0,5245 -0,0395 = -7.00%
    Slotkoers 08 mrt. 2024 0,506 -0,0185 = -3.53%
    Slotkoers 15 mrt. 2024 0,545 +0,039 = +7.71%
    Slotkoers 22 mrt. 2024 0,521 -0,024 = -4.40%
    Slotkoers 28 mrt. 2024 0,517 -0,004 = -0.77%
    Slotkoers 05 apr. 2024 0,515 -0,002 = -0.39%
    Slotkoers 12 apr. 2024 0,593 +0,078 = +15.15%
    Slotkoers 19 apr. 2024 0,830 +0,237 = +39.97% Wauw, wat een super week zeg!!
    Slotkoers 26 apr. 2024 0,819 -0,011 = -1.33%
    Slotkoers 03 mei 2024 0,787 -0,032 = -3.91%
    Slotkoers 10 mei 2024 0,788 +0,001 = +0.13%
    Slotkoers 17 mei 2024 0,721 -0,067 = -8.50%
    Slotkoers 24 mei 2024 0,777 +0,056 = +7.77%

    Jaarrendement t.o.v. van 31 december 2023 +0,064 = +8.98%

    Maandrendementen: (t.o.v. slot vorige maand)

    Slotkoers 31 jan. 2024 0,6185 -0,0945 = -13.25%
    Slotkoers 29 feb. 2024 0,515 -0,1035 = -16.73%
    Slotkoers 28 mrt. 2024 0,517 +0,002 = +0.39%
    Slotkoers 30 apr. 2024 0,831 +0,314 = +60.74% !!!!!
    Slotkoers 17 mei 2024 0,777 -0,054 = -6.50%
  18. forum rang 10 DeZwarteRidder 30 mei 2024 09:26

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 24494

      Gegeven: 10621

    •    Aantal posts: 102.376

    30 May NCYT – Full Year 2023 Results (30.05.2024)
    in Board, News

    Novacyt S.A.

    (“Novacyt”, the “Company” or the “Group”)

    Full Year 2023 results
    Integration of Yourgene Health remains on track
    Laying the foundations for future growth

    Paris, France, and Eastleigh and Manchester, UK – 30 May 2024 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces its audited results for the year ended 31 December 2023. The results include almost four months’ trading of Yourgene Health Limited (formerly plc) (“Yourgene”) following its acquisition by the Group, which completed on 8 September 2023.

    Operational Highlights (including post year-end and Yourgene 2023 activities pre-acquisition)

    Completed the strategic acquisition of Yourgene, significantly enhancing Novacyt’s global diagnostics business, adding scale and diversification to accelerate long-term growth.
    Lyn Rees and John Brown CBE joined the Novacyt Board as Executive and Non-Executive Director respectively.
    Lyn Rees appointed Chief Executive Officer following a six-year tenure as CEO of Yourgene Health plc, bringing over 28 years’ global healthcare leadership and commercial experience.
    Steve Gibson appointed CFO, and to join the Board along with Dr Jo Mason, CSO, subject to shareholder approval.
    IVDR certification: received first IVDR accreditation for the Yourgene DPYD genotyping assay for chemotoxicity in chemotherapy patients; submitted application for Cystic Fibrosis quantitative fluorescence PCR (QF-PCR) test.
    Yourgene became a compatible partner of PacBio, a leading global developer of sequencing technology, supporting the use of the LightBench™ instrument (Ranger® Technology) to its global customer base.
    Yourgene launched MagBench™ automated DNA extraction platform for NIPT workflows in Asia-Pacific and the Middle East.
    Launch of the Primer Design Co-Prep ES instrument, providing automated DNA and RNA extraction using Primer Design assays, for use in multiple applications.
    Primer Design launched a range of “complete” assays, including customised mastermix reagent for RUO customers.

    Financial Highlights

    Acquired the AIM-listed company Yourgene and its subsidiaries for an all-cash consideration of £16.7m on 8 September 2023.
    Group statutory revenue for FY2023 was £11.6m, in line with guidance, of which £0.6m relates to COVID-19 (FY2022*: £21.0m, of which £14.7m related to COVID-19).
    Group statutory revenue for the non-COVID-19 portfolio of £11.0m represents circa 95% of total revenue (FY2022*: £6.3m).
    Group gross profit totalled £3.7m (32%) in FY2023 (FY2022: £5.7m (27%)). This was reduced predominantly as a result of providing for all remaining COVID-19 associated stock, in addition to writing off stock that had not been provided for previously. Excluding the impact of these items, the Group gross profit margin would be in excess of 60%.
    Group EBITDA loss in FY2023 totalled £13.7m before exceptional items (FY2022: £13.5m loss).
    Loss after tax increased to £28.3m in FY2023 (FY2022: £25.7m loss).
    Completed cost savings actions that will deliver over £4.0m of bottom-line improvement, the Group is tracking ahead of schedule on the targeted synergies to be achieved from the Yourgene acquisition.
    Cash position at 31 December 2023 was £44.1m (2022: £87.0m), reflecting the cash consideration and associated costs of the acquisition of Yourgene. The Group remains debt free.

    *excludes any Yourgene revenue as pre-acquisition

    Commenting on the results Lyn Rees, CEO of Novacyt, said: “2023 was a transitional year for Novacyt, during which the Group completed the acquisition of Yourgene, a significant milestone that has enhanced our global diagnostics capabilities, diversified our product portfolio and increased the scale of our non-COVID-19 revenues.

    “We continue to focus all efforts towards working as a single business so that the reorganisation of the Group and the resulting synergies will leave us well placed to deliver future growth. We remain focused on driving the global sales of our key clinical and instrumentation products, while also rebuilding our RUO business. The Board believes that investment in R&D combined with our commercial strength is key to achieving long-term growth and we are increasingly well-placed to execute our business strategy.”
  19. forum rang 10 DeZwarteRidder 30 mei 2024 09:28

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 24494

      Gegeven: 10621

    •    Aantal posts: 102.376

    Loss after tax increased to £28.3m in FY2023 (FY2022: £25.7m loss).
    Completed cost savings actions that will deliver over £4.0m of bottom-line improvement, the Group is tracking ahead of schedule on the targeted synergies to be achieved from the Yourgene acquisition.

    Cash position at 31 December 2023 was £44.1m (2022: £87.0m), reflecting the cash consideration and associated costs of the acquisition of Yourgene. The Group remains debt free.
  20. forum rang 10 DeZwarteRidder 30 mei 2024 12:54

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 24494

      Gegeven: 10621

    •    Aantal posts: 102.376

    Vileine zegt:

    30 mei 2024 12:40
    Volgens het forum van Boursorama:
    Kortom: Genfit heeft een theoretische waardering van €1 miljard, oftewel een koersdoel van €20.
    Verwachte gebeurtenissen: FDA MA (10 juni) + EMA MA (??) + positieve ACLF P2 resultaten die volgende week op het EASL-congres zullen worden gepresenteerd
  21. Pjotr 30 mei 2024 12:59

    • Pjotr

      Lid sinds: 04 jan 2018

      Laatste bezoek: 05 mrt 2025

    • Aanbevelingen

      Ontvangen: 172

      Gegeven: 109

    •    Aantal posts: 514

    quote:

    DeZwarteRidder schreef op 30 mei 2024 12:54:

    Vileine zegt:

    30 mei 2024 12:40
    Volgens het forum van Boursorama:
    Kortom: Genfit heeft een theoretische waardering van €1 miljard, oftewel een koersdoel van €20.
    Verwachte gebeurtenissen: FDA MA (10 juni) + EMA MA (??) + positieve ACLF P2 resultaten die volgende week op het EASL-congres zullen worden gepresenteerd
    verkeerde forum?
70.915 Posts
Pagina: «« 1 ... 3518 3519 3520 3521 3522 ... 3546 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.083
AB InBev 2 5.522
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.795
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.755
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.755
Aedifica 3 922
Aegon 3.258 322.936
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.895
Agfa-Gevaert 14 2.051
Ahold 3.538 74.343
Air France - KLM 1.025 35.117
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.043
Alfen 16 24.961
Allfunds Group 4 1.506
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.825
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.444
AMG 971 133.833
AMS 3 73
Amsterdam Commodities 305 6.697
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.025
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.787
Arcelor Mittal 2.034 320.816
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.327
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.358
ASML 1.766 108.446
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 520
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.688
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.404